Medication info
Paralidine Tablets 20 Milligrams (Famotidine)

Paralidine Tablets 20 Milligrams (Famotidine)

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
(Stock Company) Genupharm
Appearance
Green circular film-coated tablet
Packaging
300 tablets/bottle
Approval status
Active

MFDS item code 198900881 · Notified 1989.02.15 · Insurance code 698000230

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers, gastroesophageal reflux disease); preanesthetic medication; improvement of gastric mucosal lesions
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine 20mg orally twice daily (after breakfast and dinner, or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection; switch to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine 10mg orally twice daily (after breakfast and dinner, or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve famotidine 20mg in 20ml of physiological saline injection or dextrose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Switch to oral administration once oral dosing is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20ml of physiological saline injection or dextrose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After reconstitution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
(Stock Company) Genupharm

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers, gastroesophageal reflux disease); preanesthetic medication; improvement of gastric mucosal lesions

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal injection
  • gastric mucosal swelling
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding, and acute stress ulcers. It is also effective in suppressing bleeding due to hemorrhagic gastritis and alleviating the symptoms of gastroesophageal reflux disease and Zollinger-Ellison syndrome. It helps improve gastric mucosal lesions occurring during acute exacerbations of acute gastritis and chronic gastritis to support gastric health. As an injectable, it is used not only for upper gastrointestinal bleeding but also for pre-anesthetic medication to stabilize the patient's condition. Overall, it is employed to effectively improve and treat symptoms of gastrointestinal diseases.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine 20mg orally twice daily (after breakfast and dinner, or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection; switch to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine 10mg orally twice daily (after breakfast and dinner, or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve famotidine 20mg in 20ml of physiological saline injection or dextrose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Switch to oral administration once oral dosing is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20ml of physiological saline injection or dextrose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After reconstitution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients allergic to specific ingredients or in those with a genetic problem of lactose intolerance. Patients sensitive to medications, those with kidney or liver dysfunction, patients with heart diseases, and elderly individuals should use this medicine with special caution. This medication can cause severe allergic reactions, blood disorders, serious symptoms on the skin and mucous membranes, liver dysfunction or muscle damage, cardiac rhythm abnormalities, and consciousness disturbances. If any unusual symptoms occur, use should be discontinued immediately and a doctor should be consulted. During treatment, the therapeutic effects and side effects should be monitored closely, and regular blood tests, liver, and kidney function tests should be conducted. This medication is designed to dissolve in the mouth but must be swallowed with saliva or water; it is not absorbed directly from the oral mucosa. If patients on hemodialysis use specific calcium preparations with this medication, the efficacy may decrease, so caution is needed. There may be interactions with other medications, specifically when used with certain antifungals or anticancer agents, which may reduce effectiveness, so consultation with a physician is essential. Elderly patients are at risk of increased drug concentration due to reduced kidney function, so doses should be reduced or dosing intervals extended with caution. The safety of this medication during pregnancy has not been established, so it should only be used when absolutely necessary. Nursing mothers should discontinue breastfeeding as the drug may pass into breast milk. Use in children should be avoided as safety has not been adequately confirmed. This medication can be placed on the tongue and allowed to dissolve with saliva, but must be taken with water, and should not be taken while lying down. Additionally, this medication may mask symptoms of gastric cancer, so it is important to confirm the nature of the malignancy before use.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • respiratory distress
  • systemic rash
  • angioedema
  • facial swelling
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 85 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Lyell's syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • increased serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized seizures
  • tonic seizures
  • clonic seizures
  • interstitial nephritis
  • acute renal failure
  • fever
  • rash
  • erythema
  • urticaria
  • facial swelling
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • loose stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated AST
  • elevated ALT
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • abnormal liver function
  • jaundice
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucination
  • anxiety
  • agitation
  • decreased libido
  • sensory disturbances
  • feeling of heaviness
  • reversible confusional state
  • depression
  • seizures
  • altered consciousness
  • dizziness
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle spasms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It should be kept away from direct sunlight and stored at normal room temperature.

Appearance and packaging

Appearance

Green circular film-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.